{"id":"https://openalex.org/W1604750871","doi":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","title":"Dosing Feasibility And Pharmacokinetics By Seizure Type And Status, And Tolerability Of Intranasal Diazepam In Adults With Epilepsy (S31.006)","display_name":"Dosing Feasibility And Pharmacokinetics By Seizure Type And Status, And Tolerability Of Intranasal Diazepam In Adults With Epilepsy (S31.006)","publication_year":2014,"publication_date":"2014-04-08","ids":{"openalex":"https://openalex.org/W1604750871","doi":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","mag":"1604750871"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.82.10_supplement.s31.006","doi":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004620817","display_name":"Michael R. Sperling","orcid":"https://orcid.org/0000-0003-0708-6006","observed_orcids":["https://orcid.org/0000-0003-0708-6006","https://orcid.org/0000-0002-1166-3825"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Sperling","raw_affiliation_strings":["Thomas Jefferson University Philadelphia PA United States","6Thomas Jefferson University Philadelphia PA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University Philadelphia PA United States","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"6Thomas Jefferson University Philadelphia PA United States","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052595296","display_name":"Hussam Seif Eddeine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325481341","display_name":"St. Joseph's Hospital and Medical Center","ror":"https://ror.org/00m72wv30","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hussam Seif Eddeine","raw_affiliation_strings":["St. Joseph'S Hospital Phoenix AZ United States","5St. Joseph'S Hospital Phoenix AZ United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Joseph'S Hospital Phoenix AZ United States","institution_ids":["https://openalex.org/I1325481341"]},{"raw_affiliation_string":"5St. Joseph'S Hospital Phoenix AZ United States","institution_ids":["https://openalex.org/I1325481341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110500416","display_name":"Kevin F. Haas","orcid":"https://orcid.org/0000-0001-8444-3551","observed_orcids":["https://orcid.org/0000-0001-8444-3551"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Haas","raw_affiliation_strings":["Vanderbilt University Medical Center Nashville TN United States","7Vanderbilt University Medical Center Nashville TN United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center Nashville TN United States","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"7Vanderbilt University Medical Center Nashville TN United States","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062520786","display_name":"Gregory L. Krauss","orcid":"https://orcid.org/0000-0002-0338-6039","observed_orcids":["https://orcid.org/0000-0002-0338-6039"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Krauss","raw_affiliation_strings":["John Hopkins University Baltimore MD United States","3John Hopkins University Baltimore MD United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Hopkins University Baltimore MD United States","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"3John Hopkins University Baltimore MD United States","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084030156","display_name":"Herbert R. Henney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28806726","display_name":"Acorda Therapeutics (United States)","ror":"https://ror.org/01788sq40","country_code":"US","type":"company","lineage":["https://openalex.org/I28806726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert Henney III","raw_affiliation_strings":["Acorda Therapeutics, Inc. Ardsley NY United States","2Acorda Therapeutics, Inc. Ardsley NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]},{"raw_affiliation_string":"2Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086311824","display_name":"Adri\u00e1n L. Rabinowicz","orcid":"https://orcid.org/0000-0003-1299-0606","observed_orcids":["https://orcid.org/0000-0003-1299-0606"]},"institutions":[{"id":"https://openalex.org/I28806726","display_name":"Acorda Therapeutics (United States)","ror":"https://ror.org/01788sq40","country_code":"US","type":"company","lineage":["https://openalex.org/I28806726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian Rabinowicz","raw_affiliation_strings":["Acorda Therapeutics, Inc. Ardsley NY United States","2Acorda Therapeutics, Inc. Ardsley NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]},{"raw_affiliation_string":"2Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032960807","display_name":"Gary Bream","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799610660","display_name":"North Carolina Institute of Medicine","ror":"https://ror.org/042eghf65","country_code":"US","type":"other","lineage":["https://openalex.org/I2799610660"]},{"id":"https://openalex.org/I4210105596","display_name":"Morrison Tech","ror":"https://ror.org/017g1tr52","country_code":"US","type":"education","lineage":["https://openalex.org/I4210105596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Bream","raw_affiliation_strings":["Neuronex, Inc. Morrisville NC United States","4Neuronex, Inc. Morrisville NC United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuronex, Inc. Morrisville NC United States","institution_ids":[]},{"raw_affiliation_string":"4Neuronex, Inc. Morrisville NC United States","institution_ids":["https://openalex.org/I2799610660","https://openalex.org/I4210105596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003276436","display_name":"David Squillacote","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28806726","display_name":"Acorda Therapeutics (United States)","ror":"https://ror.org/01788sq40","country_code":"US","type":"company","lineage":["https://openalex.org/I28806726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Squillacote","raw_affiliation_strings":["Acorda Therapeutics, Inc. Ardsley NY United States","2Acorda Therapeutics, Inc. Ardsley NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]},{"raw_affiliation_string":"2Acorda Therapeutics, Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058896099","display_name":"Enrique J. Carrazana","orcid":"https://orcid.org/0000-0001-8788-0722","observed_orcids":["https://orcid.org/0000-0001-8788-0722"]},"institutions":[{"id":"https://openalex.org/I28806726","display_name":"Acorda Therapeutics (United States)","ror":"https://ror.org/01788sq40","country_code":"US","type":"company","lineage":["https://openalex.org/I28806726"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrique Carrazana","raw_affiliation_strings":["Acorda Therapeutics Inc. Ardsley NY United States","1Acorda Therapeutics Inc. Ardsley NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acorda Therapeutics Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]},{"raw_affiliation_string":"1Acorda Therapeutics Inc. Ardsley NY United States","institution_ids":["https://openalex.org/I28806726"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2533,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.60037238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"82","issue":"10_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.8759999871253967},{"id":"https://openalex.org/keywords/seizure-clusters","display_name":"seizure clusters","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7820000052452087},{"id":"https://openalex.org/keywords/seizure-types","display_name":"seizure types","score":0.6759999990463257},{"id":"https://openalex.org/keywords/tonic-clonic-seizures","display_name":"tonic-clonic seizures","score":0.875},{"id":"https://openalex.org/keywords/epilepsy-monitoring-unit","display_name":"epilepsy monitoring unit","score":0.7910000085830688},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7799999713897705},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9070000052452087},{"id":"https://openalex.org/keywords/seizure-free-period","display_name":"seizure-free period","score":0.3540000021457672},{"id":"https://openalex.org/keywords/adult-epilepsy","display_name":"adults with epilepsy","score":0.5789999961853027},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8379268646240234},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.7171324491500854},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.703315258026123},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6863388419151306},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6372071504592896},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6170591115951538},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.47747278213500977},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3156043589115143},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3038181662559509},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21499162912368774},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.12302780151367188}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.82.10_supplement.s31.006","doi":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.s31.006","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.75,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2168901639","https://openalex.org/W4412365625","https://openalex.org/W3018315638","https://openalex.org/W4224095667","https://openalex.org/W7204276313","https://openalex.org/W4389367972","https://openalex.org/W3195873071","https://openalex.org/W4389465053","https://openalex.org/W2149875618","https://openalex.org/W7211970344"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"the":[3,54,140,153,160,227,259,299],"dosing":[4],"feasibility":[5],"and":[6,16,31,90,96,107,117,126,157,177,193,213,218,248,268,286,290,312],"pharmacokinetics":[7],"of":[8,75,143,216,242,261,306,318],"diazepam":[9,81],"nasal":[10,264],"spray":[11],"(D-NS)":[12],"by":[13],"seizure":[14,105,113,167,172,220,280,292],"type":[15,106],"status":[17],"following":[18,66,152,170,288],"a":[19,73,144,165,315],"single-dose":[20,74],"in":[21,50,159],"adults":[22],"with":[23,208,240,281,298],"epilepsy.":[24],"Additional":[25],"goals":[26],"were":[27,83,98,114,119,124,137,149,188,224,256],"to":[28,53,87,103,110,258,275,304],"assess":[29],"safety":[30],"tolerability.":[32],"BACKGROUND:":[33],"A":[34],"D-NS":[35,76,201,271,294],"formulation":[36],"is":[37],"under":[38],"development":[39],"for":[40,93,179],"treating":[41],"cluster":[42],"seizures.":[43,236],"DESIGN/METHODS:":[44],"An":[45],"open-label":[46],"study":[47],"was":[48,133,238,295],"conducted":[49],"patients":[51,71,123,136,276],"admitted":[52],"epilepsy":[55],"monitoring":[56],"unit":[57],"(EMU).":[58],"After":[59],"discontinuing":[60],"or":[61,169],"reducing":[62],"prior":[63],"anti-seizure":[64],"drugs,":[65],"standard":[67],"EMU":[68],"protocols,":[69],"eligible":[70],"received":[72],"approximating":[77],"0.2mg/kg":[78],"bodyweight.":[79],"Plasma":[80],"concentrations":[82],"measured":[84],"serially":[85],"up":[86],"12h":[88],"post-dose":[89,112,235],"pharmacokinetic":[91,129],"parameters":[92],"Cmax,":[94],"Tmax,":[95],"AUC0-12":[97,178],"estimated.":[99],"Dosing":[100],"time":[101],"relative":[102],"seizure,":[104,147],"events":[108,244],"relating":[109],"first":[111],"recorded.":[115],"Safety":[116],"tolerability":[118],"assessed.":[120],"RESULTS:":[121],"Thirty-one":[122],"dosed":[125,138,150,181],"30":[127],"provided":[128],"data;":[130],"mean":[131],"age":[132],"35years.":[134],"Ten":[135],"during":[139,182,205,211,226,285],"ictal":[141,184,212],"phase":[142],"tonic-clonic":[145],"(TC)":[146],"7":[148],"\u22645min":[151],"last":[154],"clonic":[155],"jerk,":[156],"13":[158],"post-ictal":[161,214],"period,":[162],"\u88055min":[163],"after":[164],"TC":[166,183,206,217,289],"(n=4)":[168],"other":[171,219,291],"types":[173],"(n=9).":[174],"Dose-normalized":[175],"Cmax":[176],"those":[180],"versus":[185,191,195],"all":[186],"others":[187],"similar;":[189],"194":[190],"216ng/mL":[192],"1258":[194],"1212h\u00b7ng/mL,":[196],"respectively.":[197],"This":[198],"shows":[199],"that":[200],"can":[202,272],"be":[203,273],"administered":[204,274],"seizures":[207],"effective":[209,283],"delivery":[210,284],"phases":[215],"types.":[221,293],"Twenty":[222],"(65%)":[223],"seizure-free":[225],"12-h":[228],"observation":[229],"period":[230],"whereas":[231],"11":[232],"(35%)":[233],"had":[234],"Treatment":[237],"well-tolerated,":[239],"74%":[241],"adverse":[243],"(AEs)":[245],"being":[246],"mild":[247],"25%":[249],"moderate.":[250],"The":[251],"4":[252],"most":[253,300],"common":[254,301],"AEs":[255,302],"related":[257,303],"route":[260,305],"administration:":[262],"dysguesia(26%),":[263],"discomfort(23%),":[265],"increased":[266],"lacrimation(16%)":[267],"rhinorrhea(16%).":[269],"CONCLUSIONS:":[270],"experiencing":[277],"an":[278],"epileptic":[279],"equally":[282],"immediately":[287],"generally":[296],"well-tolerated":[297],"administration.":[307],"Funding:":[308],"Acorda":[309,319],"Therapeutics,":[310],"Inc,":[311,314],"Neuronex,":[313],"wholly-owned":[316],"subsidiary":[317]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}